Neonatal Sepsis Declines Globally, Disparities Persist, India Faces High Burden

The claim that neonatal sepsis is falling, but not everywhere, is largely accurate and supported by real-time information. Globally, the age-standardized incidence rate (ASIR) and age-standardized mortality rate (ASMR) for neonatal sepsis and other neonatal infections (NSNI) have shown a consistent downward trend from 1990 to 2021. The global ASIR decreased by 20.61%, and ASMR by 21.19% over this period, with an average annual rate of decline of 0.75% for both. This reduction in mortality is a positive development, often attributed to advancements in medical care, increased awareness, and specific interventions, particularly for early-onset sepsis (EOS). For instance, the incidence of EOS has notably declined due to widespread prenatal screening for Group B Streptococcus (GBS) in pregnant women and the implementation of intrapartum antibiotic prophylaxis. However, the article's nuance, 'but not everywhere,' is critically important and well-substantiated. Despite global progress, significant disparities persist across different regions and socioeconomic strata. Low and low-middle Socio-demographic Index (SDI) regions continue to bear the highest burden of neonatal sepsis. Mortality rates exhibit an inverse correlation with SDI, meaning that higher SDI regions have experienced more rapid reductions in mortality. In 2021, Southern Sub-Saharan Africa recorded the highest ASIR, while Western Sub-Saharan Africa had the highest ASMR, highlighting the geographical concentration of this health challenge. For India, the situation remains particularly challenging. Neonatal sepsis is a major cause of death among infants in the first 28 days of life, posing a significant obstacle to reducing newborn mortality in the country and other low- and middle-income countries (LMICs). India accounts for nearly a quarter of the estimated 550,000 infection-related neonatal deaths globally each year. Studies reveal high rates of neonatal sepsis, with one paper indicating that 34.6% of newborns in Special Newborn Care Units (SNCUs) in district-level hospitals in India suffered from this infection. Furthermore, a concerning aspect for India is the alarmingly high rate of antimicrobial resistance (AMR), with 75% to 88% of isolated pathogens being multidrug-resistant, which significantly complicates treatment efforts and renders many standard treatments ineffective. While a study in rural Gadchiroli, India, demonstrated a substantial decline in neonatal sepsis incidence (from 111.2 per 1000 live births in 1998-2001 to 18.6 per 1000 live births in 2016-2019), this local success underscores the potential for intervention but also the variability across different parts of the country. South Asia, as a broader region, consistently reports a burden of neonatal sepsis that is 2-4 times higher than that in the United Kingdom and the United States. Another critical observation is the distinction between declining age-standardized rates and a potential increase in overall prevalence. The European Medical Journal article notes that while age-standardized rates of neonatal sepsis showed consistent declines from 1990–2021, *prevalence increased year on year*, which authors attribute to improved detection methods over time. This suggests that more cases are being identified, even as the risk per capita is decreasing, pointing to improved diagnostic capabilities and surveillance. Similarly, data from the Global Burden of Disease study 2019 indicated a rise in the *number of incident cases* of NSNIs globally by 12.79% from 1990 to 2019, while the number of deaths declined. Socioeconomic factors play a crucial role in neonatal sepsis outcomes. Mortality from neonatal sepsis shows strong positive associations with indicators like the Global Hunger Index and food insecurity, and inverse associations with the Inequality Adjusted Human Development Index. This indicates that markers of structural disadvantage are closely linked to where newborn deaths from neonatal sepsis are concentrated. Additionally, disparities in childhood sepsis outcomes have been noted based on race/ethnicity and insurance status, with higher mortality observed in Black children and in specific regions, such as the American South, highlighting the pervasive impact of social determinants of health. Prematurity and low birth weight are also significant risk factors for neonatal sepsis, leading to higher incidence and mortality rates due to the neonate's compromised immune system. In conclusion, while global efforts have led to a decline in age-standardized incidence and mortality rates of neonatal sepsis, the fight is far from over. The uneven distribution of progress, particularly the persistent high burden in LMICs like India and the escalating challenge of antimicrobial resistance, necessitates continued, targeted interventions, robust epidemiological research, and equitable health resource allocation to further reduce the global impact of this devastating condition.

Frequently Asked Questions

Read Full Story on Quick Digest